Normando Iznaga-Escobar
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Genetics
- Co-authors
- Mayra RamosRolando PérezRené FigueredoEduardo FernándezOlga TorresAgustín LageTania CrombetTeresa Cruz
- Topics
- Radiopharmaceutical Chemistry and Applications (18 papers)Monoclonal and Polyclonal Antibodies Research (14 papers)HER2/EGFR in Cancer Research (10 papers)
In The Last Decade
Normando Iznaga-Escobar
25 papers receiving 609 citations
Peers
Comparison fields: 5 of 74
- Oncology 327
- Radiology, Nuclear Medicine and Imaging 301
- Pulmonary and Respiratory Medicine 196
- Molecular Biology 161
- Genetics 70
Countries citing papers authored by Normando Iznaga-Escobar
This map shows the geographic impact of Normando Iznaga-Escobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Normando Iznaga-Escobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Normando Iznaga-Escobar more than expected).
Fields of papers citing papers by Normando Iznaga-Escobar
This network shows the impact of papers produced by Normando Iznaga-Escobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Normando Iznaga-Escobar. The network helps show where Normando Iznaga-Escobar may publish in the future.
Co-authorship network of co-authors of Normando Iznaga-Escobar
This figure shows the co-authorship network connecting the top 25 collaborators of Normando Iznaga-Escobar. A scholar is included among the top collaborators of Normando Iznaga-Escobar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Normando Iznaga-Escobar. Normando Iznaga-Escobar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 4 | |
| 3 | 7 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 25 | |
| 8 | 6 | |
| 9 | 36 | |
| 10 | 14 | |
| 11 | 237 | |
| 12 | 7 | |
| 13 | 25 | |
| 14 | 13 | |
| 15 | 25 | |
| 16 | 12 | |
| 17 | 15 | |
| 18 | 99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy. | 43 |
| 19 | 7 | |
| 20 | 35 |
About Normando Iznaga-Escobar
Normando Iznaga-Escobar is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Toxicology, having authored 25 papers that have together received 622 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (18 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and HER2/EGFR in Cancer Research (10 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (301 citations), Otorhinolaryngology (55 citations) and Oncology (327 citations). Normando Iznaga-Escobar has collaborated with scholars based in Cuba, Uruguay and India. Frequent co-authors include Mayra Ramos, Rolando Pérez, René Figueredo, Eduardo Fernández, Olga Torres, Agustín Lage, Tania Crombet, Teresa Cruz, I. Leonard and Marta Osorio. Their work appears in journals such as Journal of Clinical Oncology, International Immunopharmacology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.